Incidence of multidrug resistant coagulase negative Staphylococci in clinical samples of Tertiary care hospitals of Khairpur and Sukkur cities of Pakistan

Paper Details

Research Paper 01/10/2016
Views (282) Download (4)

Incidence of multidrug resistant coagulase negative Staphylococci in clinical samples of Tertiary care hospitals of Khairpur and Sukkur cities of Pakistan

Shahida Mangi, Anwar Hussain Phulpoto, Muneer Ahmed Qazi, Nisar Ahmed Kanhar
Int. J. Biosci.9( 4), 261-269, October 2016.
Certificate: IJB 2016 [Generate Certificate]


Coagulase-negative staphylococci (CoNS) adopting multidrug resistance have been increasingly becoming a threat to the patients in tertiary care hospitals worldwide. The aim of present study was to find out the incidence of multidrug-resistant CoNS in various samples of clinical origin. A total of 280 clinical samples of different origin were collected from tertiary care hospitals of Khairpur and Sukkur cities of Pakistan. Coagulase-negative staphylococci (CoNS) were isolated and identified using routine microbiological techniques and molecular characterization using 16S rRNA sequence-based homology. The antimicrobial sensitivity was determined using Kirby-Bauer’s disc-diffusion assay and penicllin zone-edge test. Overall, 44 (21.15%) samples were found positive for Gram positive staphylococci, i.e. 35(80%) coagulase-positive and 9(20%) coagulase-negative. The highest percent prevalence of CoNS was found in urine samples 2/6(33%) and ear swab 1/3(33%) followed by throat swab 1/4(25%) and pus 5/27(19.1%). The results of antibiotic sensitivity profiling revealed complete resistance of the pus isolate CoNS5 to all the antibiotics tested. The phylogenetic correlation of amplified 16S rRNA gene sequence of CoNS5 isolate shared 98% similarity with Staphylococcus haemolyticus ATCC 29970 (GenBank accession no. D83367). Prevalence of extended multidrug-resistant pathogen S. haemolyticusin clinical specimenscalls for timely control measures against next superbug after methicillin-resistant S. aureus (MRSA).


Akelere JO, Anyadoh-Nwadike SO, Nwadike PO. 2013. Prevalence and antibiogram of multi-drug resistant Staphylococcus aureus among pregnant women attending ante-natal clinics in Owerri, Imo State, Nigeria. Asian Journal of Medical Sciences 4(3), pp.8-14. DOI: v4i3.6221

Brzychczy-Wloch M, Borszewska-Kornacka M, Gulczynska E, Wojkowska-Mach J, Sulik M, Grzebyk M, Luchter M, Heczko PB, Bulanda M. 2013. Prevalence of antibiotic resistance in multi-drug resistant coagulase-negative staphylococci isolated from invasive infection in very low birth weight neonates in two Polish NICUs. Annals of clinical microbiology and antimicrobials 12(1), p.1. DOI: 10.1186/1476-0711-12-41

Cavanagh JP, Hjerde E, Holden MT, Kahlke T, Klingenberg C, Flægstad T, Parkhill J, Bentley SD, Sollid JUE. 2014. Whole-genome sequencing reveals clonal expansion of multiresistant Staphylococcus haemolyticus in European hospitals. Journal of Antimicrobial Chemotherapy 69(11), pp.2920-2927. DOI: 10.1093/jac/dku271

Cheesbrough M. 2006. District laboratory practice in tropical countries. Cambridge university press.

Dimitriou G, Fouzas S, Giormezis N, Giannakopoulos I, Tzifas S, Foka A, Anastassiou DE, Spiliopoulou I, Mantagos S. 2011. Clinical and microbiological profile of persistent coagulase‐negative staphylococcal bacteraemia in neonates. Clinical Microbiology and Infection 17(11), pp.1684-1690. DOI: 10.1111/j.1469-0691.2011.03489.x

Dowzicky MJ, Park CH. 2008. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007. Clinical therapeutics 30(11), pp.2040-2050. DOI:10.1016 /j.clinthera.2008.11.006

Feßler AT, Calvo N, Gutiérrez N, Bellido JLM, Fajardo M, Garduño E, Monecke S, Ehricht R, Kadlec K, Schwarz S. 2013. Cfr-mediated linezolid resistance in methicillin-resistant Staphylococcus aureus and Staphylococcus haemolyticus associated with clinical infections in humans: two case reports. Journal of Antimicrobial Chemotherapy p.dkt331. DOI: 10.1093/jac/dkt331

Fredheim EGA, Klingenberg C, Rohde H, Frankenberger S, Gaustad P, Flægstad T, Sollid JE. 2009. Biofilm formation by Staphylococcus haemolyticus. Journal of clinical microbiology 47(4), pp.1172-1180. DOI: 10.1128/ JCM.01891-08

Gheibi S, Karamyyar M, Ilkhanizadeh B, Asghari-Sana F, Mahmoodzadeh H, Majlesi AH. 2008. Coagulase negative Staphylococcus; the most common cause of neonatal septicemia in Urmia, Iran. Iranian journal of Pediatrics 18(3), pp.237-243.

Han JE, Hwang SY, Kim JH, Shin SP, Jun JW, Chai JY, Park YH, Park SC. 2013. CPRMethicillin resistant coagulase-negative staphylococci isolated from South Korean ducks exhibiting tremor. Acta Veterinaria Scandinavica 55(1), p.1. DOI: 10.1186 /1751-0147-55-88

Khan S, Sallum UW, Zheng X, Nau GJ, Hasan T. 2014. Rapid optical determination of β-lactamase and antibiotic activity. BMC microbiology 14(1), p.1. DOI: 10.1186/1471-2180-14-84

Kim JW, Chung GT, Yoo JS, Lee YS, Yoo JI. 2012. Autolytic activity and molecular characteristics of Staphylococcus haemolyticus strains with induced vancomycin resistance. Journal of medical microbiology 61(10), pp.1428-1434. DOI: 10.1099/ jmm.0.041046-0

Naseer U, Sundsfjord A. 2011. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microbial drug resistance 17(1), pp.83-97. DOI:10.1089/mdr.2010.0132.

NCCLS. 2012. Performance standards for antimicrobial disk susceptibility tests: approved standards; 22nd informational supplement: Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.

Pereira EM, Schuenck RP, Malvar KL, Iorio NL, Matos PD, Olendzki AN, Oelemann WM, dos Santos KR. 2010. Staphylococcus aureus, Staphylococcus epidermidis and Staphylococcus haemolyticus: methicillin-resistant isolates are detected directly in blood cultures by multiplex PCR. Microbiological Research 165(3), 243-249. DOI. org/10.1016/j.micres.2009.03.003

Qu Y, Daley AJ, Istivan TS, Garland SM, Deighton MA. 2010. Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation. Annals of Clinical Microbiology and Antimicrobial 9(16), 1-12. DOI: 10.1186/1476-0711-9-16

Roth AL, Thomson KS, Lister PD, Hanson ND. 2012. Production of KPC-2 alone does not always result in β-lactam MICs representing resistance in Gram-negative pathogens. Journal of Clinical Microbiology 50(12), 4183-4184. DOI: 10.1128/ JCM.02194-12

Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE. 2002. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110(2), 285-291.

Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. 2009. Plasmid-mediated quinolone resistance: a multifaceted threat. Clinical Microbiology Review 22(4), 664-689. DOI: 10.1128 /CMR.00016-09

Tamura K, Nei M. 1993. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Molecular biology and evolution 10(3), 512-526.

Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6: molecular evolutionary genetics analysis version 6.0. Molecular biology and evolution 30(12), 2725-2729. DOI: 10.1093/molbev /mst197

Thomson KS. 2010. Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. Journal of clinical microbiology 48(4), 1019-1025. DOI: 10.1128/JCM.00219-10

Thomson KS. 2013. Detection of gram-negative β-lactamase producing pathogens in the clinical lab. Current pharmaceutical design 19(2), 250-256. DOI:

Vignaroli C, Biavasco F, Varaldo PE. 2006. Interactions between glycopeptides and β-lactams against isogenic pairs of teicoplanin-susceptible and-resistant strains of Staphylococcus haemolyticus. Antimicrobial Agents and Chemotherapy 50(7), 2577-2582. DOI: 10.1128/AAC.00260-06

Wachino JI, Arakawa Y. 2012. Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update. Drug Resistance Update 15(3), 133-148. DOI:10.1016/j.drup.2012.05.001